SynthesisScientific reports2022
Comparing CABG and PCI across the globe based on current regional registry evidence.
Synthesis in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis.BMC cardiovascular disorders · 2024Pooled it
- Five-year outcomes of percutaneous coronary intervention and coronary artery bypass grafting for multivessel disease: a national population-based study of regional practice.European heart journal open · 2026Article
- TAP (T and Small Protrusion) and Culotte Stenting Techniques Versus a Reverse Crush in Case of Bailout of Provisional Stenting.Journal of cardiovascular development and disease · 2026Article
- Fast-Track Extubation After Cardiac Surgery: A Narrative Review.Journal of cardiovascular development and disease · 2025Review
- Trends in cardiac surgery and percutaneous interventions in New York: a statewide registry analysis (2010-2019).BMC cardiovascular disorders · 2025Article
- SAVR and TAVI comparison across the globe based on current regional registry evidence - A meta-analysis of reconstructed time-to-event data.International journal of cardiology. Heart & vasculature · 2025Article
- 'Vaccination' against myocardial infarction: the hidden long-term effect of coronary artery bypass grafting.Open heart · 2025Article
- Article
- Targeted metabolomic profiling reveals inflammation-associated longitudinal changes in plasma metabolites following on-pump coronary bypass surgery.Frontiers in medicine · 2025Article
- Article
- Evolution of the Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) Indication and Mortality Rates in Spain from 2010 to 2019.Journal of cardiovascular development and disease · 2024Article
- Innovative pathways in revascularization for non-ST elevation acute coronary syndrome.JTCVS open · 2024Article
- Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease.Journal of the American Heart Association · 2024Article
- Article
- Correlation Between Uric Acid/High Density Lipoprotein Cholesterol Ratio and Postoperative AKI in Patients with CABG.International journal of general medicine · 2024Article
- Invasive Treatment of Left Main Coronary Artery Disease: From Anatomical Features to Mechanistic Differences.Current cardiology reviews · 2024Review
- Evaluate the Quality of Life in Patients With Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft.Cureus · 2024Article
- Impact of Post-Operative Infection after CABG on Long-Term Survival.Journal of clinical medicine · 2023Article
- Late Clinical Outcomes of Total Arterial Revascularization or Multiple Arterial Grafting Compared to Conventional Single Arterial with Saphenous Vein Grafting for Coronary Surgery.Journal of clinical medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is an ongoing debate whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) provide better results for the treatment of coronary artery disease (CAD). We aimed to evaluate the impact of CABG or PCI on long-term survival based on local reports from different regions in the world. We systematically searched MEDLINE selecting studies that compared outcomes for CABG or PCI as a treatment for CAD in the last 10 years. Reports without all-cause mortality, multi-national cohorts, hybrid revascularization populations were excluded. Qualifying studies were statistically compared, and their geographic location visualized on a world map. From 5126 studies, one randomized and twenty-two observational studies (19 risk-adjusted) met the inclusion criteria. The mean follow-up was 4.7 ± 7 years and 18 different countries were included. In 17 studies, CABG was associated with better survival during follow-up, six studies showed no significant difference, and no study favored PCI. Periprocedural mortality was not different in seven, lower with PCI in one, lower with CABG in three and not reported in 12 studies. In regional registry-type comparisons, CABG is associated with better long-term survival compared to PCI in most regions of the world without evidence for higher periprocedural mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.